No Data
No Data
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Intellia Therapeutics Analyst Ratings
Needham Maintains Buy on Recursion Pharmaceuticals, Lowers Price Target to $16
Recursion Pharmaceuticals Analyst Ratings
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
10x Genomics GAAP EPS of -$0.32 Beats by $0.16, Revenue of $153.1M Beats by $3.05M
Forever 365 :
OceansWave : A lot of market moving events for this week.. so have you started to sell puts for NVDA? I am loading on the stock hahahah
Cow Moo-ney OP OceansWave : Haven’t haha. Waiting for lower price to sell put and to load up shares
OceansWave : Haha